Similar Search Results

The changing landscape of off-label prescription drug promotion : opportunities to improve decision-making

Sarkees, Matthew E.; Fitzgerald, M. Paula - In: International journal of pharmaceutical and healthcare … 10 (2016) 2, pp. 148-160

Persistent link: https://www.econbiz.de/10011591731

The pandemic ripple effect : understanding marketing and public policy opportunities in the pharmaceutical industry

Sarkees, Matthew E.; Bone, Paula Fitzgerald; Lamberton, Cait - In: Journal of public policy & marketing 40 (2021) 1, pp. 103-104

Persistent link: https://www.econbiz.de/10012534349

Pharmaceuticals, marketing, and society : a new center of gravity for critical research and policy : editorial

Sarkees, Matthew E.; Bone, Paula Fitzgerald; Lamberton, Cait - In: Journal of public policy & marketing 41 (2022) 4, pp. 299-303

Persistent link: https://www.econbiz.de/10013384446

Whose view is it anyway? : media coverage of litigation in for-profit firms' role in the opioid crisis

Gratz, Elizabeth T.; Sarkees, Matthew E.; Bone, Paula … - In: Journal of marketing theory and practice : JMTP 30 (2022) 4, pp. 440-456

Persistent link: https://www.econbiz.de/10013358800

The changing landscape of off-label prescription drug promotion

Sarkees, Matthew E.; Fitzgerald, M. Paula - In: International Journal of Pharmaceutical and Healthcare … 10 (2016) 2, pp. 148-160

Purpose Off-label drug prescribing by healthcare providers is a growing practice. Yet, the US Food and Drug Administration bans the marketing of drugs for off-label uses. In recent years, legal challenges by the pharmaceutical industry have chipped away government restrictions on off-label drug...

Persistent link: https://www.econbiz.de/10014796109